Belite Bio stock soars 65% in wake of strong IPO performance
Belite Bio (BLTE) stock soared 65% on Tuesday on the heels of a strong performance last Friday following its $36M initial public offering
Source: seekingalpha.com
Stay updated with breaking news from Bio Seeks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio (BLTE) stock soared 65% on Tuesday on the heels of a strong performance last Friday following its $36M initial public offering
Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share